Cargando…
Blood fibrinogen level as a biomarker of adverse outcomes in patients with coronary artery disease: A systematic review and meta-analysis
BACKGROUND: The association between elevated fibrinogen level and adverse outcomes in patients with coronary artery disease (CAD) remains conflicting. This systematic review and meta-analysis aims to evaluate the association between fibrinogen level and adverse outcomes in CAD patients. METHODS: Rel...
Autores principales: | Cui, Zhanqian, Zhao, Guowei, Liu, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387956/ https://www.ncbi.nlm.nih.gov/pubmed/35984145 http://dx.doi.org/10.1097/MD.0000000000030117 |
Ejemplares similares
-
Fibrinogen is Associated with Clinical Adverse Events in Patients with Psoriasis and Coronary Artery Disease
por: Zhao, Lin, et al.
Publicado: (2023) -
Plasminogen and fibrinogen plasma levels in coronary artery disease
por: Lima, Luciana Moreira, et al.
Publicado: (2012) -
Plasminogen and fibrinogen plasma levels in coronary artery disease
por: Kazmi, Rashid S., et al.
Publicado: (2012) -
Fibrinogen–albumin ratio predicting major adverse cardiovascular outcomes post‐percutaneous coronary intervention: A systematic review and exploratory meta‐analysis
por: Desai, Rupak, et al.
Publicado: (2023) -
Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease
por: Liu, Shuo-Lin, et al.
Publicado: (2020)